Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
146.9 USD | +1.09% | -0.07% | -6.30% |
06-02 | GSK blood cancer drug nearly halves risk of death in late-stage trial | RE |
06-01 | US lawmakers ask FBI for briefing on GenScript Biotech's links to China | RE |
Sales 2024 * | 88.35B 120B | Sales 2025 * | 90.82B 124B | Capitalization | 353B 481B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 30.03B | Net income 2025 * | 23.09B 31.46B | EV / Sales 2024 * | 3.93 x |
Net cash position 2024 * | 6.18B 8.43B | Net cash position 2025 * | 19.02B 25.91B | EV / Sales 2025 * | 3.68 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
15.4
x | Employees | 131,900 |
Yield 2024 * |
3.29% | Yield 2025 * |
3.43% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +1.09% | ||
1 week | -0.07% | ||
Current month | +0.13% | ||
1 month | -2.04% | ||
3 months | -9.41% | ||
6 months | -7.27% | ||
Current year | -6.30% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 254 M€ | +13.69% | - | |
12.91% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 146.7 | +0.96% | 14,621,203 |
24-05-30 | 145.3 | +0.58% | 8,491,111 |
24-05-29 | 144.4 | +0.04% | 8,263,810 |
24-05-28 | 144.4 | -1.76% | 10,499,829 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.30% | 353B | |
+40.73% | 739B | |
+32.83% | 598B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- JNJ Stock